Manager Journal
    Facebook Twitter Instagram
    Manager Journal Manager Journal
    • Home
    • Archive
      • 2025
        • 2025, Vol. 41, Issue 1, May
        • 2025, Vol. 42, Issue 2, December
      • 2024
        • 2024, Vol. 39, Issue 1, May
        • 2024, Vol. 40, Issue 2, December
      • 2023
        • 2023, Vol. 37, Issue 1, May
        • 2023, Vol. 38, Issue 2, December
      • 2022
        • 2022, Vol. 35, Issue 1, May
        • 2022, Vol. 36, Issue 2, December
      • 2021
        • 2021, Vol. 33, Issue 1, May
        • 2021, Vol. 34, Issue 2, December
      • 2020
        • 2020, Vol. 31, Issue 1, May
        • 2020, Vol. 32, Issue 2, December
      • 2005-2019
        • 2019
          • 2019, Vol. 29, Issue 1, May
          • 2019, Vol. 30, Issue 2, December
        • 2018
          • 2018, Vol. 27, Issue 1, May
          • 2018, Vol. 28, Issue 2, December
        • 2017
          • 2017, Vol. 25, Issue 1, May
          • 2017, Vol. 26, Issue 2, December
        • 2016
          • 2016, Vol. 23, Issue 1, May
          • 2016, Vol. 24, Issue 2, December
        • 2015
          • 2015, Vol. 21, Issue 1, May
          • 2015, Vol. 22, Issue 2, December
        • 2014
          • 2014, Vol. 19, Issue 1, May
          • 2014, Vol. 20, Issue 2, December
    • Our Authors
    • Journal Information
      • Authors Guidelines
      • Open Acces
      • Indexing
      • Aims and scope
      • Editorial Board
      • Activity Report
    • Submit a manuscript
    Manager Journal
    Home»2015»Criminal falsification of medicines in EU
    2015

    Criminal falsification of medicines in EU

    Adrian Victor VeveraBy Adrian Victor VeveraApril 26, 2021Updated:November 1, 2021No Comments1 Min Read

     Pages: 175-182

    Introduction. Falsified medicines are fake medicines that pass themselves off as real, authorized medicines. Falsified medicines might contain ingredients, including active ingredients, which are of bad quality or in the wrong dose – either too high or too low. As they have not been properly evaluated to check their quality, safety and efficacy – as required by strict EU authorization procedures – this could be detrimental to your health.

    Aim of the study. This paper aims to highlight Falsified medicines (the term ‘falsified’ is used to distinguish the issue from IP violations, so-called ‘counterfeits’) are a major threat to public health and safety. As falsifications become more sophisticated, the risk that falsified medicines reach patients in the EU increases every year. Falsified medicines represent a serious threat to global health and call for a comprehensive strategy both at European and international level.

    Keywords: Falsified medicines, health, safety, European Union, international level

    Full text sources
    European Union Falsified medicines Health international level safety
    Adrian Victor Vevera

    Related Posts

    Romania – social transfers as tool for reducing poverty

    December 9, 2023

    ONLINE EDUCATION CHALLENGES IN THE NEW ERA OF GLOBALIZATION

    February 19, 2022

    Best practices of social entrepreneurship in Romania

    July 11, 2021

    Civil Society Organizations’ Contribution To Democratic Governance In European Union

    May 5, 2021
    Add A Comment

    Leave A Reply Cancel Reply

    Recent Posts
    • Navigating Uncertainty: Insights from Romanian Entrepreneurs on Opportunity Recognition, Resource Use, and Business Resilience during the COVID-19 Crisis
    • Telework and the Virtual Communication
    • Fiscal Challenges in Public Debt Management – a Romanian Perspective
    • Ethical Marketing In The Ai Era – A Strategic Necessity For Modern Companies
    • Review of Informality and Housing using Science Mapping Review Methodology: A Bibliometric Analysis.
    Recent Comments

      Type above and press Enter to search. Press Esc to cancel.